Title: | Long COVID research: an update from the PHOSP-COVID Scientific Summit |
Authors: | Brightling, CE Evans, RA Singapuri, A Smith, N Wain, LV Brightling, CE Evans, RA Wain, LV Chalmers, JD Harris, VC Ho, LP Horsley, A Houchen-Wolloff, L Marks, M Raman, B Singapuri, A Barran, P Bingham, M Chilvers, ER Daynes, E Efstathiou, CM Elneima, O Guillen Guio, B Harrison, EM Jenkins, RG Liew, F Lone, NI Lord, JM McAuley, HJC McCann, GP Mitchell, J Plekhanova, T Russell, RJ Saunders, RM Semple, MG Smith, N Trivedi, D Turtle, L Walker, S Abel, K Adamali, H Adeloye, D Adeyemi, O Adrego, R Aguilar Jimenez, LA Ahmad, S Ahmad Haider, N Ahmed, R Ahwireng, N Ainsworth, M Al-Sheklly, B Alamoudi, A Ali, M Aljaroof, M Allan, L Allen, RJ Allerton, L Allsop, L Allt, AM Almeida, P Altmann, D Alvarez Corral, M Amoils, S Anderson, D Antoniades, C Arbane, G Arias, A Armour, C Armstrong, L Armstrong, N Arnold, D Arnold, H Ashish, A Ashworth, A Ashworth, M Aslani, S Assefa-Kebede, H Atkin, P Atkin, C Aul, R Aung, H Austin, L Avram, C Ayoub, A Babores, M Baggott, R Bagshaw, J Baguley, D Bailey, L Baillie, JK Bain, S Bakali, M Bakau, M Baldry, E Baldwin, M Baldwin, D Ballard, C Banerjee, A Bang, D Barker, RE |
Issue Date: | 16-Oct-2023 |
Publisher: | Elsevier |
Citation: | Brightling, C.E. et al. on behalf of the PHOSP-COVID Collaborative Group (2023) 'Long COVID research: an update from the PHOSP-COVID Scientific Summit', The Lancet Respiratory Medicine, 11 (11), pp. e93 - e94. doi: 10.1016/S2213-2600(23)00341-7. |
Abstract: | The severity of acute SARS-CoV-2 infection has decreased with the introduction of public health policies, vaccination, improved management of acute disease, and a degree of protective immunity in those who have survived past infection. However, in the wake of the pandemic, post-acute sequelae of COVID-19—referred to as long COVID—have emerged. The UK National Institute for Health and Care Excellence (NICE) describes long COVID as a condition in which signs and symptoms continue or develop after acute COVID-19 (>4 weeks), including ongoing symptomatic COVID-19 and post-COVID-19 syndrome (≥12 weeks). |
URI: | https://bura.brunel.ac.uk/handle/2438/28325 |
DOI: | https://doi.org/10.1016/S2213-2600(23)00341-7 |
ISSN: | 2213-2600 |
Other Identifiers: | ORCiD: Claire M Nolan https://orcid.org/0000-0001-9067-599X |
Appears in Collections: | Dept of Health Sciences Research Papers
|